Síndrome Respiratória Aguda Grave e a COVID-19 (SARS-Cov-2): uma revisão narrativa

Maria Soraya Pereira Franco Adriano, Betânia Maria Pereira Santos, Carmem Gabriela Gomes de Figueiredo Figueiredo, Ana Carolina Bernardes Dulgheroff, Ronaldo Rodrigues Sarmento, Felipe Gonçalves Bezerra, Maryanne Pereira Franco Adriano, João Felipe Bezerra

Resumo


Objetivo: Analisar a produção científica acerca da atual pandemia do novo coronavírus, destacando aspectos referentes às características do vírus, bem como a epidemiologia, o diagnóstico e tratamento da COVID-19 no intuito de fornecer informações aos profissionais de saúde e à comunidade científica. Método: Revisão narrativa, com busca nas bases de dados Scielo, Medline, Lilacs e Pubmed, referente ao período de fevereiro a maio de 2020, utilizando os descritores: “infecções por coronavírus” or “coronavirus infections”, “COVID-19”, “betacoronavirus”, “Síndrome Respiratória Aguda Grave”, “SARS-Cov-2”, “diagnóstico”, “diagnosis”. Resultados: Foram evidenciadas três categorias temáticas: aspectos referentes ao vírus; a epidemiologia e a clínica da doença; e aspectos do diagnóstico e tratamento. Conclusão: O Coronavírus sofreu mutações desde o início da pandemia, mas não se sabe se estas mutações afetaram seu poder de infecciosidade. Em diferentes partes do mundo a epidemiologia da COVID-19 foi diferente. Com relação ao tratamento, a droga que tem se mostrado mais promissora até o momento é o remdesivir. Sem uma vacina eficaz, a maior arma que dispomos é o isolamento social.

Descritores: Infecções por Coronavírus; COVID-19; Síndrome Respiratória Aguda Grave. 


SEVERE ACUTE RESPIRATORY SYNDROME AND COVID-19 (SARS-COV-2): A NARRATIVE REVIEW

Objective: To analyze a scientific production on the current pandemic of new coronaviruses, highlighting aspects related to virus resources, as well as the epidemiology, diagnosis and treatment of COVID-19 in order to provide information to health professionals and the scientific community. Method: Narrative review, searching the Scielo, Medline, Lilacs and Pubmed databases, for the period from February to May 2020, using the keywords: "coronavirus infections" or "coronavirus infections", "COVID-19", "Betacoronavirus", "Severe Acute Respiratory Syndrome", "SARS-Cov-2", "diagnosis", "diagnosis". Results: Three thematic categories were highlighted: aspects related to the virus; an epidemiology and disease clinic; and aspects of diagnosis and treatment. Conclusion: The Coronavirus has mutated since the beginning of the pandemic, but it is not known whether these mutations have affected its infectiousness. In different parts of the world the epidemiology of COVID-19 was different. Regarding treatment, a drug that has been shown to be more promising until recovery is needed. Without an effective vaccine, the biggest weapon that affects social isolation.

Descriptors: Coronavirus Infections; COVID-19; Severe Acute Respiratory Syndrome. 


SÍNDROME RESPIRATORIO AGUDO GRAVE Y COVID-19 (SARS-COV-2): UNA REVISIÓN NARRATIVA

Objetivo: analizar una producción científica sobre la pandemia actual de nuevos coronavirus, destacando aspectos relacionados con los recursos del virus, así como la epidemiología, diagnóstico y tratamiento de COVID-19 para proporcionar información a los profesionales de la salud y la comunidad científica. Método: Revisión narrativa, buscando en las bases de datos Scielo, Medline, Lilacs y Pubmed, para el período de febrero a mayo de 2020, utilizando los descriptores: "infecciones por coronavirus" o "infecciones por coronavirus", "COVID-19", "Betacoronavirus", "Síndrome respiratorio agudo severo", "SARS-Cov-2", "diagnóstico", "diagnóstico". Resultados: se destacaron tres categorías temáticas: aspectos relacionados con el virus; una clínica de epidemiología y enfermedad; y aspectos de diagnóstico y tratamiento. Conclusión: el coronavirus ha mutado desde el comienzo de la pandemia, pero no se sabe si estas mutaciones han afectado su infecciosidad. En diferentes partes del mundo, la epidemiología de COVID-19 fue diferente. Con respecto al tratamiento, un medicamento que ha demostrado ser más prometedor hasta que se necesita recuperación. Sin una vacuna efectiva, el arma más grande que afecta el aislamiento social.

Descriptores: Infecciones por Coronavirus; COVID-19; Síndrome Respiratorio Agudo Severo.


Texto completo:

PDF

Referências


World Health Organization. Coronavirus disease (COVID-19) Situation Report – 109 [Internet]. 2020 fev [cited 2020 May 08]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/.

De Salazar PM, Niehus R, Taylor A, Buckee CO, Lipsitch M. Identifying Locations with Possible Undetected Imported Severe Acute Respiratory Syndrome Coronavirus 2 Cases by Using Importation Predictions. Emerg Infect Dis [internet]. 2020 [cited 2020 Apr 08]; 26(7). Available from: https://doi.org/10.3201/eid2607.200250.

Velavan TP, Meyer GG. The Covid-19 epidemic. Tropical Med. Int. Health. v. 25, n.3, p. 278-280, 2020. Trop Med Int Health [internet]. 2020 [cited 2020 mar 30]; 25(3): 278-280. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169770/.

Nishiura H, Linton NM, Akhmetzhanov AR. Initial cluster of novel coronavirus (2019-nCoV) infections in Wuhan, China is consistent with substantial human-to-human transmission. J. Clin. Med [internet]. 2020 [cited 2020 mar 20]; 9(2): 488. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073724/.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med [internet]. 2020 [cited 2020 mar 20]; 382(8): 727-733. Available from: doi: 10.1056/NEJMoa2001017.

Lin X, Gong Z, Xiao Z, Xiong J, Fan B, Liu J. Novel coronavirus pneumonia outbreak in 2019: Computed tomographic findings in two cases. Korean J. Radiol [internet]. 2020 [cited 2020 apr 09]; 21(3): 365-368. Available from: doi: 10.3348/kjr.2020.0078.

Wang To KK, Tsang OT, Yip CC, Chan KH, Wu TC, Chan JMC, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis [internet]. 2020 [cited 2020 mar 03]; ciaa149. Available from: https://pubmed.ncbi.nlm.nih.gov/32047895/.

Bastola A, Sah R, Rodriguez-Morales AJ, Lal BK, Jha R, Ojha HC, et al. The first 2019 novel coronavirus case in Nepal. Lancet Infect. Dis [internet]. 2020 [cited 2020 apr 03]; 20(3): 279-280. Available from: https://pubmed.ncbi.nlm.nih.gov/32057299/.

Rother ET. Revisão sistemática X revisão narrativa. Acta paul. Enferm [internet]. 2007 [cited 2020 may 02]; 20(2): 1-8. Available from:https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-21002007000200001&lng=en&nrm=iso&tlng=pt.

Mota M, Cunha M, Santos M, Cunha ICKO, Alves M, Marques N. Intervenções de enfermagem pré-hospitalar: revisão narrativa. Enfermagem em foco [internet]. 2019 [cited 2020 may 05]; 10(4): 1-9. Available from: http://revista.cofen.gov.br/index.php/enfermagem/article/view/2527.

Santos MG, Bitencourt JVOV, Silva TG, Frizon G, Quinto AS. Etapas do processo de enfermagem: uma revisão narrativa. Enfermagem em foco [internet]. 2017 [cited 2020 may 05]; 8(4): 49-53. Available from: http://revista.cofen.gov.br/index.php/enfermagem/article/view/1032/0.

Fauci AS, Lane C, Redfield RR. Covid-19-Navigating the Uncharted. N Engl J Med [internet]. 2020 [cited 2020 mar 30]; 382(13): 1268-1269. Available from: doi: 10.1056/NEJMe2002387.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet [internet]. 2020 [cited 2020 mar 30]; 395(10224): 565–574. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30251-8/fulltext.

Guan W, Ni ZY, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med[internet]. 2020 [cited 2020 apr 28]; 382(18): 1708-1720. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2002032.

Li Q, Med M, Guan X, Wu P, Wuang X, Zhou L, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N Engl J Med [internet]. 2020 [cited 2020 apr 03]; 382(13): 1199-1207. Available from: nejm.org/doi/full/10.1056/NEJMoa2001316.

Michael TM, Currie DW, Clark S, Pogosjans S,Kay M, Schwartz G, et al. Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington. N Engl J M [internet]. 2020 [cited 2020 apr 09]; 382(21): 2005-2011. Available from: doi: 10.1056/NEJMoa2005412.

Knoops K, Kikkert M, Van Den Worm SHE, Zevenhoven-Dobbe JC, Van Der Meer Y, Koster AJ, et al. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol [internet]. 2008 [cited 2020 apr 10] 16;6(9): e226. Available from: doi: 10.1371/journal.pbio.0060226.

Masters PS. The molecular biology of coronaviruses. Adv Virus Res [internet]. 2006 [cited 2020 mar 03]; 66: 193-292. Available from: doi: 10.1016/S0065-3527(06)66005-3.

Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. Journal of Pharmaceutical Analysis [internet]. 2020 [cited 2020 may 4]; 10(2): 102-108. Available from: https://www.sciencedirect.com/science/article/pii/S2095177920302045.

Raj VS, Mou H, Smits SL, Dekkers DHW, Müller MA, Dijkman R, et al., Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature [internet]. 2013 [cited 2020 mar 09]; 495(7440): 251–254. Available from: doi: 10.1038/nature12005.

Barlan A, Zhao J, Mayukh K, Li K, McCray Jr PB, Perlman S, et al., Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection. J Virol [internet]. 2014 [cited 2020 apr 02]; 88(9): 4953–4961. Available from: doi: 10.1128/JVI.00161-14.

Chu H, Chan JF-W, Yuen TT, Shuai H, Yuan S, MPhill YW, et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. The Lancet Microbe [internet]. 2020 [cited 2020 apr 30]; 1(1): e14-e23. Available from: doi: 10.1016/S2666-5247(20)30004-5.

Jeffers AS, Tusell SM, Gillim-Ross L, Hemmila EM, Achenbach JE, Babcock GJ, et al. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A [internet]. 2004 [cited 2020 apr 8]; 101(44): 15748–15753. Available from: https://www.pnas.org/content/101/44/15748.

Ross SW, Lauer CW, Miles WS, Green JM, Christmas AB, May AK, et al. Maximizing the Calm Before the Storm: Tiered Surgical Response Plan for Novel Coronavirus (COVID-19). Journal of the American College of Surgeons [internet]. 2020 [cited 2020 apr 04]; Available from: https://www.journalacs.org/article/S1072-7515(20)30263-5/pdf.

Du Toit A. Outbreak of a novel coronavirus. Nat. Rev. Microbiol [internet]. 2020 [cited 2020 apr 03];18(3): 123. Available from: https://pubmed.ncbi.nlm.nih.gov/31988490/.

Ren LL, Wang YM., Wu ZQ, Xiang ZC, Guo L, Xu T. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chinese Med J [internet]. 2020 [ cited may 08];133(9):1015-1024. Available from: doi: 10.1097/CM9.0000000000000722.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [internet]. 2020 [cited mar 22]; 395(10223): 497–506. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext.

Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci. Trends [internet]. 2020 [cited 2020 may 01]; 14(1): 69-71. Avalialble from: https://doi.org/10.5582/bst.2020.01020.

Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J. Med. Virol [internet]. 2020 [cited 2020 may 01]; 92(4):441–447. Available from: doi: 10.1002/jmv.25689.

Nishiura H, Jung SM, Linton NM, Kinoshita R, Yang Y, Hayashi K. The extent of transmission of novel coronavirus in wuhan, China, 2020. J. Clin. Med [internet]. 2020 [cited 2020 feb 20]; 24;9(2): 330. Available from: doi: 10.3390/jcm9020330.

Bassetti M, Vena A, Roberto Giacobbe D. The Novel Chinese Coronavirus (2019-nCoV) Infections: challenges for fighting the storm. Eur. J. Clin. Invest [internet]. 2020 [cited 2020 apr 02]; 50(3): e13209. Available from: doi: 10.1111/eci.13209.

Rodriguez-Morales AJ. COVID-19 in Latin America: The implications of the first confirmed case in Brazil. Travel Med Infect Dis [internet]. 2020 [cited 2020 mar 01]; 101613. Available from: doi: 10.1016/j.tmaid.2020.101613.

Brasil. Ministério da Saúde. Painel Coronavírus. 2020 may [cited 2020 May 08]. Available from: https://covid.saude.gov.br.

Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana YP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis [internet]. 2020 [2020 apr 01]; 34: 101623. Available from: doi: 10.1016/j.tmaid.2020.101623.

Centers for Disease Control and Prevention. Guidelines for samples for COVID-19. 2020 feb [cited 2020 May 08]. Available from: https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html.

Imai K, Tabata S, Ikeda M, Nocuchi S, Kitagawa Y, Matuoka M, et al. Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19. J Clin Virol [internet]. 2020 [cited 2020 may 08]; 128: 104393. Available from: doi: 10.1016/j.jcv.2020.104393.

Corman, VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill [internet]. 2020 [cited 2020 feb 27]; 25(3): 2000045. Available from: doi : 10.2807/1560-7917.ES.2020.25.3.2000045.

Mungmunpuntipantip R, Wiwanitkit V. Uncertainty in using chest computed tomography in early coronavirus disease (COVID-19). Can J Anesth [internet]. 2020 [cited 2020 may 08]; 67(7): 897. Available from: https://pubmed.ncbi.nlm.nih.gov/32240519.

Akiyama MJ, Spaulding AC, Rich JD. Flattening the Curve for Incarcerated Populations — Covid-19 in Jails and Prisons. NEJM Group [internet]. 2020 [cited 2020 may 07]; 382: 2075-2077. Available from: doi.10.1056/NEJMp2005687.

Yasaka TM, Lehrich BM, Sahyouni R. Peer-to-Peer Contact Tracing: A Privacy-Preserving Smartphone app. JMIR Mhealth Uhealth [internet]. 2020 [cited 2020 apr 20]; 8(4): e18936. Available from: doi: 10.2196/18936.

Felsenstein S, Herbert JN, Mcnamara OS, Hedrich CM. COVID-19: Immunology and treatment options. Clin Immunol [internet]. 2020 [cited 2020 may 01]; 215: 108448. Available from: doi: 10.1016/j.clim.2020.108448.

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res [internet]. 2020 [cited 2020 apr 07]; 30(3): 269–271. Available from: doi: 10.1038/s41422-020-0282-0.

Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends [internet]. 2020 [cited 2020 mar 28]; 14(1): 72–73. Available from: doi: 10.5582/bst.2020.01047.

Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents [internet]. 2020 [cited 2020 apr 16]; 105949. Available from: doi: 10.1016/j.ijantimicag.2020.105949.

Molina JM, Delaugerre C, Le Goff J, Mela-Lima B, Ponscarme D, Goldwirt L, et al. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. Med Mal Infect [internet]. 2020 [cited 2020 may 03]; 50(4): 384. Available from:doi: 10.1016/j.medmal.2020.03.006.

Magagnoli JN, Narendran S, Pereira F, Cummings T, Hardin JW, Sutton SS, et al. Outcomes of Hydroxychloroquine usage in United States veterans hospitalized with COVID-19. medRciv Server. 2020 apr [cited 2020 may 02]. Available from: https://www.medrxiv.org/content/10.1101/2020.04.16.20065920v2.

Borba MGS, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Brito M, et al. Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study) medRxiv Preprint. 2020 apr [cited 2020 may 03]. Available from: https://www.medrxiv.org/content/10.1101/2020.04.07.20056424v1.full.pdf

Mehra MR, Desai SS, Ruschitzka F, Patel NA. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet [internet]. 2020 [cited 2020 may 28]; 6736(20): 31180-31186. Available from: https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2931180-6.

Gordon CJ, Tchesnokov EP, Feng JY, Porter DP, Gotte M. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J Biol Chem [internet]. 2020 [cited 2020 may 05]; 295(15): 4773–4779. Available from: doi: 10.1074/jbc.AC120.013056.

Holshue ML, DeBolt C, Lindquist S, Tang HJ, Hsueh PR. First Case of 2019 Novel Coronavirus in the United States. Int J Antimicrob Agents [internet]. 2020 [cited 2020 mar 27]; 55(3):105924. Available from: doi: 10.1016/j.ijantimicag.2020.105924.

Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med [internet]. 2020 [cited 2020 may 06]; NEJMoa2007016. Available from: doi: 10.1056/NEJMoa2007016.




DOI: https://doi.org/10.21675/2357-707X.2020.v11.n2.ESP.3775

Apontamentos

  • Não há apontamentos.


Direitos autorais 2020 Enfermagem em Foco

Licença Creative Commons
Esta obra está licenciada sob uma licença Creative Commons Atribuição 4.0 Internacional.

Eletrônico ISSN: 2357-707X

Impresso ISSN: 2177-4285

Licença Creative Commons
Este trabalho está licenciado com uma Licença Creative Commons - Atribuição 4.0 Internacional.